跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 42 条关于
“myofibroblast”
全部
42
临床试验
12
药物
0
机构
0
资讯
30
上个月
Mediar Therapeutics Enters Collaboration with Ono Pharma to Develop Novel Antibody Therapeutics for Fibro-inflammatory Diseases
去年
aTyr Pharma Advances Novel Anti-Fibrotic Therapy ATYR0101 for Pulmonary Fibrosis
10个月前
Mabwell's Anti-IL-11 Antibody 9MW3811 Becomes World's First IL-11 Therapeutic to Enter Phase II for Pathological Scarring
3个月前
Nanomedicine-Driven Precision Therapy for Renal Fibrosis: Bridging Molecular Mechanisms and Targeted Delivery
8个月前
Mediar Therapeutics Secures $76 Million Series B to Advance First-in-Class Anti-Fibrotic Pipeline
2年前
Mediar Therapeutics Advances Fibrosis Treatment with Phase 1 Trial of MTX-463
4年前
Insilico Medicine's AI-Discovered Drug Enters First-in-Human Trials for Idiopathic Pulmonary Fibrosis
去年
Endeavor BioMedicines Receives Dual Orphan Drug Designation for Taladegib in Idiopathic Pulmonary Fibrosis
去年
Lilly and Mediar Therapeutics Partner to Advance Novel IPF Therapy
去年
Mediar Therapeutics Initiates Phase 2 Trial of First-in-Class Anti-WISP1 Antibody for Idiopathic Pulmonary Fibrosis
第 1 页,共 3 页
上一页
下一页